Jerzak K - Search Results

1

Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care.

Roberts A, Hallet J, Nguyen L, Coburn N, Wright FC, Gandhi S, Jerzak K, Eisen A, Look Hong NJ. Roberts A, et al. Among authors: jerzak k. Breast Cancer Res Treat. 2024 Jul;206(2):227-244. doi: 10.1007/s10549-024-07282-1. Epub 2024 Apr 27. Breast Cancer Res Treat. 2024. PMID: 38676808

2

Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications.

Jerzak KJ, Cockburn J, Pond GR, Pritchard KI, Narod SA, Dhesy-Thind SK, Bane A. Jerzak KJ, et al. Breast Cancer Res Treat. 2015 Jan;149(1):293-301. doi: 10.1007/s10549-014-3235-9. Epub 2014 Dec 27. Breast Cancer Res Treat. 2015. PMID: 25542270

3

The incidence of bone metastasis after early-stage breast cancer in Canada.

Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. Liede A, et al. Among authors: jerzak kj. Breast Cancer Res Treat. 2016 Apr;156(3):587-595. doi: 10.1007/s10549-016-3782-3. Epub 2016 Apr 15. Breast Cancer Res Treat. 2016. PMID: 27083181

4

Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.

Jerzak KJ, Mancuso T, Eisen A. Jerzak KJ, et al. Curr Oncol. 2018 Apr;25(2):e176-e180. doi: 10.3747/co.25.3707. Epub 2018 Apr 30. Curr Oncol. 2018. PMID: 29719442 Free PMC article. Review.

5

Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study.

Jerzak KJ, Cockburn JG, Dhesy-Thind SK, Pond GR, Pritchard KI, Nofech-Mozes S, Sun P, Narod SA, Bane A. Jerzak KJ, et al. Breast Cancer Res Treat. 2018 Oct;171(3):709-717. doi: 10.1007/s10549-018-4844-5. Epub 2018 Jun 18. Breast Cancer Res Treat. 2018. PMID: 29915948

6

Takotsubo Cardiomyopathy During Anti-HER2 Therapy for Metastatic Breast Cancer.

Lees C, Yazdan-Ashoori P, Jerzak KJ, Gandhi S. Lees C, et al. Oncologist. 2019 Feb;24(2):e80-e82. doi: 10.1634/theoncologist.2018-0285. Epub 2018 Nov 2. Oncologist. 2019. PMID: 30389744 Free PMC article.

7

Prognostic associations of plasma hepcidin in women with early breast cancer.

Jerzak KJ, Lohmann AE, Ennis M, Nemeth E, Ganz T, Goodwin PJ. Jerzak KJ, et al. Breast Cancer Res Treat. 2020 Dec;184(3):927-935. doi: 10.1007/s10549-020-05903-z. Epub 2020 Sep 22. Breast Cancer Res Treat. 2020. PMID: 32960376 Free PMC article.

8

A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer.

Brezden-Masley C, Fathers KE, Coombes ME, Pourmirza B, Xue C, Jerzak KJ. Brezden-Masley C, et al. Breast Cancer Res Treat. 2021 Jan;185(2):507-515. doi: 10.1007/s10549-020-05960-4. Epub 2020 Oct 16. Breast Cancer Res Treat. 2021. PMID: 33064230 Free PMC article.

9

A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer.

Brezden-Masley C, Fathers KE, Coombes ME, Pourmirza B, Xue C, Jerzak KJ. Brezden-Masley C, et al. Breast Cancer Res Treat. 2021 Feb;185(3):807-815. doi: 10.1007/s10549-020-05976-w. Epub 2020 Oct 22. Breast Cancer Res Treat. 2021. PMID: 33090268 Free PMC article.

10

Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features.

Meti N, Saednia K, Lagree A, Tabbarah S, Mohebpour M, Kiss A, Lu FI, Slodkowska E, Gandhi S, Jerzak KJ, Fleshner L, Law E, Sadeghi-Naini A, Tran WT. Meti N, et al. Among authors: jerzak kj. JCO Clin Cancer Inform. 2021 Jan;5:66-80. doi: 10.1200/CCI.20.00078. JCO Clin Cancer Inform. 2021. PMID: 33439725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters